Douglas A. Melton: Difference between revisions

Douglas A. Melton
Douglas A. Melton
Born	September 26, 1953
Alma mater	University of Illinois, B.S. Biology Cambridge University, B.A. History and Philosophy of Science Cambridge University, Ph.D. Molecular Biology
Awards	George Ledlie Prize, Richard Lounsbery Award, Eliot P. Joslin Medal
	Scientific career
Fields	Stem cell biology ; Developmental biology
Institutions	Harvard Stem Cell Institute; Harvard University Faculty of Arts and Sciences,; Department of Stem Cell and Regenerative Biology and; Department of Molecular and Cellular Biology; Howard Hughes Medical Institute; National Academy of Science

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 06:20, 11 August 2008

Douglas A. Melton is the co-director of the Harvard Stem Cell Institute, an investigator of the Howard Hughes Medical Institute, the Thomas Dudley Cabot Professor in the Natural Sciences of the Harvard University Faculty of Arts and Sciences, chairperson of the Harvard University Department of Stem Cell and Regenerative Biology, a faculty member of the Department of Molecular and Cellular Biology, a member of the National Academy of Science, a founding member of the International Society for Stem Cell Research, and is on the Science Advisory Board of the Genetics Policy Institute.

Melton's research in the 1980s focused on the role of RNAs in the development of the Xenopus embryo. This later shifted to general developmental biology research in Xenopus, and eventually in the mid-1990s, became centered on the development of the pancreas. His current research interests include the differentiation of human embryonic stem cells, particularly in pertinence to diabetes, as well as general and pancreatic developmental biology.

His research into stem cell therapies is motivated in part by his children's affliction with Type 1 Diabetes. He is known for pioneering work in developmental biology of the pancreas.

In 2001 when President George W. Bush cut federal funding of embryonic stem cell research, Melton used private donations to create 17 published^[1] stem cell lines and distribute them without charge to researchers around the world.

In 2007, Melton was listed among Time Magazine's 100 Most Influential People in The World.

Sources

Douglas Melton - the Time 100

References

^ Cowan, C.A. et al. "Derivation of Embryonic Stem-Cell Lines from Human Blastocysts", New England Journal of Medicine

External links

This biography of an academic is a stub. You can help Wikipedia by expanding it.

[1] Cowan, C.A. et al. "Derivation of Embryonic Stem-Cell Lines from Human Blastocysts", New England Journal of Medicine

[1]

@@ Line 31: / Line 31: @@
 }}
-'''Douglas A. Melton''' is the co-director of the [[Harvard Stem Cell Institute]], an investigator of the [[Howard Hughes Medical Institute]], the Thomas Dudley Cabot Professor in the Natural Sciences of the [[Harvard Faculty of Arts and Sciences|Harvard University Faculty of Arts and Sciences, chairperson of the [[Harvard University]] Department of Stem Cell and Regenerative Biology, a faculty member of the Department of Molecular and Cellular Biology, a member of the [[National Academy of Science]], a founding member of the [[International Society for Stem Cell Research]], and is on the Science Advisory Board of the [[Genetics Policy Institute]].
+'''Douglas A. Melton''' is the co-director of the [[Harvard Stem Cell Institute]], an investigator of the [[Howard Hughes Medical Institute]], the Thomas Dudley Cabot Professor in the Natural Sciences of the [[Harvard Faculty of Arts and Sciences|Harvard University Faculty of Arts and Sciences]], chairperson of the [[Harvard University]] Department of Stem Cell and Regenerative Biology, a faculty member of the Department of Molecular and Cellular Biology, a member of the [[National Academy of Science]], a founding member of the [[International Society for Stem Cell Research]], and is on the Science Advisory Board of the [[Genetics Policy Institute]].
+Melton's research in the 1980s focused on the role of [[RNA]]s in the development of the ''[[Xenopus]]'' embryo. This later shifted to general developmental biology research in ''Xenopus'', and eventually in the mid-1990s, became centered on the development of the [[pancreas]]. His current research interests include the differentiation of human [[embryonic stem cell]]s, particularly in pertinence to [[diabetes]], as well as general and pancreatic developmental biology.
-His research into [[stem cell therapy|stem cell therapies]] is motivated in part by his children's affliction with Type 1 [[diabetes]].  He is known for pioneering work in developmental biology of the pancreas.
+His research into [[stem cell therapy|stem cell therapies]] is motivated in part by his children's affliction with [[Type 1 Diabetes]].  He is known for pioneering work in developmental biology of the pancreas.
 In 2001 when President [[George W. Bush]] cut federal funding of embryonic stem cell research, Melton used private donations to create 17 published<ref>Cowan, C.A. et al. [http://content.nejm.org/cgi/content/extract/350/13/1353 "Derivation of Embryonic Stem-Cell Lines from Human Blastocysts"], ''New England Journal of Medicine''</ref> [[stem cell line]]s and distribute them without charge to researchers around the world.